Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹68 Cr₹109 Cr₹61 Cr₹9.13 Cr₹11 Cr

What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH is ₹68 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹68 Cr
Mar2024₹109 Cr
Mar2023₹61 Cr
Mar2022₹9.13 Cr
Mar2021₹11 Cr

How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹68 Cr
-37.42
Mar2024 ₹109 Cr
78.73
Mar2023 ₹61 Cr
567.74
Mar2022 ₹9.13 Cr
-20.30
Mar2021 ₹11 Cr -

Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,611.1 Cr -7% -6.1% -22.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹115,641.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 0.7% 5.5% 9.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-7%

-6.1%

-22.4%

SENSEX

-3.1%

-2.8%

-6.1%


You may also like the below Video Courses